Kevin Reilly is a member of the board of directors of VaxGen.
Kevin Reilly has "more than 30 years of vaccine and operational experience in the pharmaceutical industry and is the former President of Wyeth Vaccines and Nutrition. At Wyeth, he served in a variety of capacities including as the Chairman and President of Wyeth-Ayerst’s Canadian operations, Area Vice President for Wyeth’s Pacific Canada Group, Group Vice President of the Pacific Rim Group, President of Wyeth Nutritionals International in addition to serving most recently as the President of Wyeth Vaccines and Nutrition. Under his leadership, he directed the accelerated growth of Wyeth’s worldwide vaccine and nutritional business. He also served as Senior Vice President for Connaught Laboratories where his primary responsibilities included export operations and strategic development.
"Mr. Reilly received his M.B.A. from York University in Toronto and is a graduate of the Advanced Management Program at the Harvard Business School. He is also a Trustee of the Board for the Sabin Vaccine Institute and currently serves on the Board of Directors of the Immune Response Corporation and Stolle Milk Biologics Inc."
Source: VaxGen profiles.